Company: CERO
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032134
Chunk: 2057

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 2
Chunk 2057
---
Item 2. Properties.

We do not own any real estate or other physical properties. We currently
maintain our executive office in approximately 12,000 square feet of office and laboratory space in a multi-tenant building at 201 Haskins
Way in South San Francisco, California. The lease for our headquarters expires on September 30, 2026. We believe that our existing facilities
are adequate for our near-term needs. We believe that suitable additional or alternative space would be available if required in the future
on commercially reasonable terms.

Item 3. Legal Proceedings.

From time to time, we may
become involved in legal proceedings arising in the ordinary course of our business. To the knowledge of our management, there is no material
litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacity
as such.

Item 4. Mine Safety Disclosures.

Not applicable.

98

PART II

Item 5. Market for Registrant’s Common
Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Market Information

Our Common Stock and Public
Warrants are traded on Nasdaq under the symbols “CERO” and “CEROW,” respectively.

Stockholders

As of April 11, 2025, the
numbers of record holders of our Common Stock and Public Warrants were 131 and 32, respectively, not including beneficial holders whose
securities are held in street name.

Dividends

We have never declared or
paid cash dividends on our capital stock. We do not anticipate declaring or paying, in the foreseeable future, any cash dividends on our
capital stock. We intend to retain all available funds and future earnings, if any, to fund the development and expansion of our business,
and we do not anticipate paying any cash dividends in the foreseeable future. Any future determination regarding the declaration and payment
of dividends, if any, will be at the discretion of our board of directors, subject to applicable laws, and will depend on then-existing
conditions, including our financial condition, operating results, contractual restrictions, capital requirements, business prospects and
other factors our board of directors may deem relevant.

In addition, our ability
to pay cash dividends on our capital stock in the future may be limited by the terms of any future debt, issued preferred securities,
or any credit facility agreements.

Securities Authorized for Issuance under Equity
Compensation Plans

Information about our equity
compensation plans set forth